Baby boomers looking to set up their portfolios for a relaxing and rewarding retirement have plenty of factors to consider. Of course, maximizing one’s passive income in retirement is great for those…
The best way to beat persistent inflation is to invest in businesses unaffected by rising prices, like these four high-yield dividend stocks.
Dividend stocks are increasingly appealing for investors in 2025 due to their potential for steady income and resilience in volatile markets. As the economic landscape evolves, characterized by rising interest rates and…
Quality, high-yield blue chip stocks can deliver dependable passive income to help retirees offset inflation. Here are five that make sense now.
These four top dividend stocks offer dependable passive income streams and solid total return, and they are too cheap to ignore any longer.
Investors concerned about sticky inflation should look to high-yield dividend stocks in sectors that will continue to outperform. Here are five such stocks.
Here are three stocks that retirees can buy with confidence as they offer recurring, dependable dividend payouts and a degree of safety that allows for a good night's sleep.
Large-cap dividend stocks will make sense as rates continue lower next year. These four have yields greater than the 10-year Treasury note.
Analysts are positive on these five top "strong buy" stocks for this year. They make sense for growth and income investors.
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they could rally this year.
These four S&P 500 stocks pay 6% and higher dividends, have Buy ratings at top Wall Street firms, and are offering excellent entry points.
These five high-yield dividend stocks have the potential to deliver positive total returns and dependable passive income.
Shares of Pfizer (NYSE: PFE | PFE Price Prediction) lost 1.46% over the past month after gaining 3.69% the month prior. The stock’s one-year loss now stands at 6.14%. When the Big Pharma lynchpin…
Joel South These five blue-chip dividend stocks are among the best in their respective sectors and are rated Buy at major Wall Street firms.
